FDA approval Alecensa (alectinib) following surgery for people with early stage ALK positive NSCLC
On April 18, 2024, the U.S. Food and Drug Administration (FDA) approved Alecensa (alectinib) following surgical resection for people living with early-stage...
On April 18, 2024, the U.S. Food and Drug Administration (FDA) approved Alecensa...
